These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effect of fluvastatin sodium on the smooth muscle cells in atherosclerotic plaques. In vivo study using low-density lipoprotein receptor deficient Watanabe heritable hyperlipidemic (WHHL) rabbits. Shiomi M; Ito T; Tsukada T; Shiraishi M; Yata T Arzneimittelforschung; 1998 Jun; 48(6):680-5. PubMed ID: 9689427 [TBL] [Abstract][Full Text] [Related]
4. Effect of cerivastatin sodium, a new inhibitor of HMG-CoA reductase, on plasma lipid levels, progression of atherosclerosis, and the lesional composition in the plaques of WHHL rabbits. Shiomi M; Ito T Br J Pharmacol; 1999 Feb; 126(4):961-8. PubMed ID: 10193776 [TBL] [Abstract][Full Text] [Related]
5. Fibromuscular cap composition is important for the stability of established atherosclerotic plaques in mature WHHL rabbits treated with statins. Shiomi M; Ito T; Hirouchi Y; Enomoto M Atherosclerosis; 2001 Jul; 157(1):75-84. PubMed ID: 11427206 [TBL] [Abstract][Full Text] [Related]
6. Cell compositions of coronary and aortic atherosclerotic lesions in WHHL rabbits differ. An immunohistochemical study. Shiomi M; Ito T; Tsukada T; Yata T; Ueda M Arterioscler Thromb; 1994 Jun; 14(6):931-7. PubMed ID: 8199184 [TBL] [Abstract][Full Text] [Related]
7. The effect of cholesterol reduction on the endothelial function and progression of atherosclerosis in WHHL rabbits. Kroon AA; Stalenhoef AF; Buikema H; Demacker PN; de Wilde PC; Leijten PA; van Gilst WH Atherosclerosis; 1993 Nov; 103(2):221-30. PubMed ID: 8292097 [TBL] [Abstract][Full Text] [Related]
9. Lipid-lowering and antiatherosclerotic effect of NK-104, a potent 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in Watanabe heritable hyperlipidemic rabbits. Suzuki H; Yamazaki H; Aoki T; Kojima J; Tamaki T; Sato F; Kitahara M; Saito Y Arzneimittelforschung; 2000 Nov; 50(11):995-1003. PubMed ID: 11187394 [TBL] [Abstract][Full Text] [Related]
10. Preventive effect of pravastatin sodium, a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on coronary atherosclerosis and xanthoma in WHHL rabbits. Watanabe Y; Ito T; Shiomi M; Tsujita Y; Kuroda M; Arai M; Fukami M; Tamura A Biochim Biophys Acta; 1988 Jun; 960(3):294-302. PubMed ID: 3132979 [TBL] [Abstract][Full Text] [Related]
11. Pravastatin inhibits expression of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in Watanabe heritable hyperlipidemic rabbits: a new pleiotropic effect of statins. Hofnagel O; Luechtenborg B; Eschert H; Weissen-Plenz G; Severs NJ; Robenek H Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):604-10. PubMed ID: 16373606 [TBL] [Abstract][Full Text] [Related]
12. Statins alter smooth muscle cell accumulation and collagen content in established atheroma of watanabe heritable hyperlipidemic rabbits. Fukumoto Y; Libby P; Rabkin E; Hill CC; Enomoto M; Hirouchi Y; Shiomi M; Aikawa M Circulation; 2001 Feb; 103(7):993-9. PubMed ID: 11181475 [TBL] [Abstract][Full Text] [Related]
13. Suppression of established atherosclerosis and xanthomas in mature WHHL rabbits by keeping their serum cholesterol levels extremely low. Effect of pravastatin sodium in combination with cholestyramine. Shiomi M; Ito T; Watanabe Y; Tsujita Y; Kuroda M; Arai M; Fukami M; Fukushige J; Tamura A Atherosclerosis; 1990 Jul; 83(1):69-80. PubMed ID: 2117930 [TBL] [Abstract][Full Text] [Related]
14. Natural history of atherosclerosis and hyperlipidemia in heterozygous WHHL (WHHL-Hh) rabbits. II. Morphologic evaluation of spontaneously occurring aortic and coronary lesions. Esper E; Runge WJ; Gunther R; Buchwald H J Lab Clin Med; 1993 Jan; 121(1):103-10. PubMed ID: 8426070 [TBL] [Abstract][Full Text] [Related]
15. Fluvastatin suppresses atherosclerotic progression, mediated through its inhibitory effect on endothelial dysfunction, lipid peroxidation, and macrophage deposition. Bandoh T; Mitani H; Niihashi M; Kusumi Y; Kimura M; Ishikawa J; Totsuka T; Sakurai I; Hayashi S J Cardiovasc Pharmacol; 2000 Jan; 35(1):136-44. PubMed ID: 10630744 [TBL] [Abstract][Full Text] [Related]
16. Pravastatin inhibits plaque rupture and subsequent thrombus formation in atherosclerotic rabbits with hyperlipidemia. Wu G; Xie Q; Xu L; Jiang H; Huang Z; Huang C Chem Pharm Bull (Tokyo); 2013; 61(2):121-4. PubMed ID: 23207681 [TBL] [Abstract][Full Text] [Related]
17. Cholesterol-fed heterozygous Watanabe heritable hyperlipidemic rabbits: a new model for atherosclerosis. Atkinson JB; Hoover RL; Berry KK; Swift LL Atherosclerosis; 1989 Aug; 78(2-3):123-36. PubMed ID: 2783197 [TBL] [Abstract][Full Text] [Related]
18. Effects of low-dose pravastatin sodium on plasma cholesterol levels and aortic atherosclerosis of heterozygous WHHL rabbits fed a low cholesterol (0.03%) enriched diet for one year. Harsch M; Braesen JH; Niendorf A Atherosclerosis; 1997 Feb; 128(2):139-47. PubMed ID: 9050770 [TBL] [Abstract][Full Text] [Related]
19. Pactimibe stabilizes atherosclerotic plaque through macrophage acyl-CoA:cholesterol acyltransferase inhibition in WHHL rabbits. Kitayama K; Koga T; Maeda N; Inaba T; Fujioka T Eur J Pharmacol; 2006 Jun; 539(1-2):81-8. PubMed ID: 16690054 [TBL] [Abstract][Full Text] [Related]
20. Effect of combined treatment with an angiotensin II receptor antagonist and an HMG-CoA reductase inhibitor on atherosclerosis in genetically hyperlipidemic rabbits. Kato M; Sada T; Mizuno M; Kitayama K; Inaba T; Koike H J Cardiovasc Pharmacol; 2005 Oct; 46(4):556-62. PubMed ID: 16160612 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]